Form4insider filings, from the source

Company · CIK 0001869105 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

BridgeBio Oncology Therapeutics, Inc. · BBOT

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 10, 2026 AFForm 4 →Sep 14, 4:24 pm EDTMarc CoboPrincipal Accounting Officer9,241$5.52$1,12114,141—
Jul 1, 2026 FForm 4 →Jul 6, 6:00 pm EDTMarc CoboPrincipal Accounting Officer125$7.80$9755,306—
Jul 1, 2026 FForm 4 →Jul 6, 6:00 pm EDTIdan ElmelechCOO & Principal Financial Ofcr343$7.80$2,67514,495—
Jul 1, 2026 FForm 4 →Jul 6, 6:00 pm EDTYong BenChief Med & Dev Officer1,047$7.80$8,16744,576—
Jul 1, 2026 FForm 4 →Jul 6, 6:00 pm EDTPedro BeltranPresident and CEO, Director1,047$7.80$8,16744,576—
Jul 1, 2026 JForm 4 →Jul 6, 4:34 pm EDTBihua ChenDirector, 10% Owner9,056,372——6,083,221—

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 10, 2026 AForm 4 →Sep 14, 4:24 pm EDTMarc CoboPrincipal Accounting Officer43,700——43,700—
Jun 16, 2026 AForm 4 →Jun 18, 4:59 pm EDTPraveen P. TipirneniDirector31,675——31,675—
Jun 16, 2026 AForm 4 →Jun 18, 4:58 pm EDTFrank McCormickDirector31,675——31,675—
Jun 16, 2026 AForm 4 →Jun 18, 4:57 pm EDTPeter F LebowitzDirector7,289——7,289—
Jun 16, 2026 AForm 4 →Jun 18, 4:56 pm EDTRaymond J. KelleherDirector31,675——31,675—
Jun 16, 2026 AForm 4 →Jun 18, 4:55 pm EDTBihua ChenDirector, 10% Owner31,675——31,675—
Jun 16, 2026 AForm 4 →Jun 18, 4:54 pm EDTJake BauerDirector31,675——31,675—
Jun 16, 2026 AForm 4 →Jun 18, 4:53 pm EDTNeil KumarDirector31,675——31,675—